ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,127.80
0.04%
Gold vs US Dollar
2,298.93
0.03%
Brent Oil
84.135
-0.40%
Bitcoin
60,900.67
0.14%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Fulgent Genetics Inc (FLGT) Share Price

FLGT Fulgent Genetics Inc

20.36
-0.03 (-0.15%)
26 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Fulgent Genetics Inc NASDAQ:FLGT NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.03 -0.15 20.36 19.92 20.78 20.63 20.1319 20.27 194,444 21:30:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Medical Laboratories 289.21M -167.83M -5.6083 -3.63 609.56M
 Type  Size  Price  Time  Units 
 9 50 20.8442 23:39:38 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore FLGT News
04/06/202421:57EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
04/06/202421:56EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
03/06/202413:00BWFulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
28/05/202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
28/05/202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
24/05/202413:00BWFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
20/05/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for FLGT

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Fulgent Genetics Inc Articles